chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site initially was red and hot. Since then the site of injection has discolored my skin and scarred where it apparently was scratched. This is the same permament skin discoloration and scarring I have previously had from a chemo medication 12 years ago. I have had flu vaccines for every year since I had chemo and this is the first flu vaccine to cause this discoloration and scarring.
Chills and body aches; which developed into large bruising on my torso under my breasts, rash around my neck and up to my hairline in the back, on the left side of my face and in the crooks of both arms; the rash is red, pebbled in texture but not oozing..it itches like mad! Today is 9/18/15 and I am still itching, it is still spreading and I am on day 2 of Prednisone.
Administration error--patient given 0.3 ml of non-diluted (not yet reconstituted) vaccine in error by staff member
pt recv vax;c/o arm starting to swell;tx w/ atbs for cellulitis;adm to hosp for tx;
patients administered with vaccines that have undergone temperature excursion; patients administered with vaccines that have undergone temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered with vaccines that have undergone temperature excursion) and EXPIRED PRODUCT ADMINISTERED (patients administered with vaccines that have undergone temperature excursion) in a 71-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients administered with vaccines that have undergone temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered with vaccines that have undergone temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients administered with vaccines that have undergone temperature excursion) and EXPIRED PRODUCT ADMINISTERED (patients administered with vaccines that have undergone temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Vial was stored in refrigerator at the time of excursion. Vial was thawed on 28-Jan-2022.  It was reported Maximum or minimum temperatures reached as on 28-Jan-2022 temp range positive 34.7F to positive 41.2F, on 30-Jan-2022 temp range positive 34.7F to positive 41.2F which occurred for 48 hours; on 31-Jan-2022 temp range positive 34.7F to positive 41.2F for 12 hours and on 04-Feb-2022 temp range positive 35.2F to positive 41.7F for 12 hours.  It was reported that the patient did not experience any adverse event.  Treatment medications were not reported.
once the injection was started the employee push the needle further into my arm causes pain to my upper arm.
Noted L arm swelling 11/8/10 PM after 5PM approx. size of fifty cent piece; red spots (flat). On 11/9/10 AM noted (R) arm - 2 areas of swelling one dime size; one nickel size, slight flat rash. No fever.
This spontaneous report as received from a health professional (medical assistant) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 05-AUG-2015, the patient was inadvertently administered an improperly stored dose of MMR II injection, lot # J014876, exp. date: 21-NOV-2015 (strength, dose and route unspecified). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No additional information was provided. Additional information has been requested.
This is a spontaneous report from a contactable Consumer.  A 91-year-old female patient  received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3249, Expiry Date 31May2021 ), at single dose into the left arm on 20Jan2021 at 11:30 am for COVID-19 immunization. Medical history included problem with gallbladder in the last 4 months. Concomitant drugs were none.  The patient had never problem with flu and shingles shot.  On 20Jan2021, the day of vaccination the patient felt fine and told everyone it was a breeze. On 21Jan2021 morning she was getting ready to go to the store at 1130am, it was about 24 hours after getting the shot, and she felt dizzy, achy, her eyes ached and were weak, she felt feverish but had no fever and was a bit nauseated. The patient  also reported loss appetite the same day. On 22Jan2021 around 11am she felt a little better. She checked her temperature and blood pressure normal. She has had a little nausea in the evening and was dizzy.  On 23Jan2021 she felt a little weak but felt better and her appetite was better.   At the time of reporting the outcome of the events was unknown.
Patient developed a large 7 x8 cm itchy area of induration, erythema, and warm with small shallow blisters in the center of the lesion, which were filled with yellow exudate.  Treated with hydroxyzine and hydrocortisone.  No systemic signs of illness.
shoulder muscle pain; Headache; Chills; Tiredness; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 59-year-old non-pregnant female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: EN6202), via an unspecified route of administration in arm left on 28Feb2021 at 10:00 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. The medical history of the patient included heart disease & high blood pressure. The concomitant medications of the patient included lisinopril (LISINOPRIL), rosuvastatin (ROSUVASTATIN), metoprolol (METOPROLOL), coenzyme q10 [ubidecarenone] (COENZYME Q10 [UBIDECARENONE]) all taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 28Feb2021 at 10:00, the patient experienced shoulder muscle pain, headache, chills and tiredness. The patient received no treatment for the events. The outcome of the events was reported as resolving.  No follow up attempts are possible. No further information is expected.
Patient caught COVID, tested positive 02/08/2021.  1st shot: 12/18/2020 Pfizer, Left Arm IM, Lot: EJ1685 2nd shot: 01/08/2021 Pfizer, Left Arm IM, Lot: EL0142
received the recall batch of Shingrix that GSK issued on 02/10/2021; received the recall batch of Shingrix that GSK issued on 02/10/2021; This case was reported by a other health professional via call center representative and described the occurrence of recalled drug administered in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number TT2JF, expiry date 28th October 2022) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced recalled drug administered and drug dispensing error. On an unknown date, the outcome of the recalled drug administered and drug dispensing error were unknown.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient received the recall batch of Shingrix that Glaxosmithkline issued on 10th February 2021. The reporter stated that, the lot number was not 9LH3Y and was not sure if this the lot number from one of the vials. The reporter stated that, the vaccine was administered to the patient before the recall of drug. This case was 1 of 8 linked cases, reported by same reporter for different patients. The reporter consented to follow up via email.
Patient ordered VARICELLA dose # 1 ZOSTAVAX vaccine was administered Lot M017294 NDC 0006-4963-01 Exp 6/28/17.
This spontaneous report as received from a medical assistant refers to a patient of unknown age who on 28-SEP-2010, was vaccinated with the first dose of GARDASIL and on 16-AUG-2011, was vaccinated with the second dose of GARDASIL (doses, routes and lot numbers not reported). The third dose had not been administered at the time of the report. No adverse effects were reported. Additional information has been requested.
Rcd vaccine 9/27/13 A.M. 0 Fri and Sat. 9/28/13 - didn't see any unusual symptoms. Sun 9/29 - reddish patch size of deck of cards. Mon - 9/30 hot, red, slight swelling. Tx - KEFLEX 500mg once Q6 hrs.
Headache, Myalgia, Arthralgia, Fever, chills, sore throat Narrative: took apap only
Pal (L) leg, shoulder and neck - said started few days after shot. No fever - orally, or at injection site, no redness as far as client can see, a little "bump" at injection site.
Pruritus with pain/swelling to anterior posterior of left thigh where received vaccines on 6/17/04. Erythema, edematous, warm area approx 15cm wide and 10 cm in height to anterior left thigh, mildly tender to palpation. Cellulitis vs sterile abscess to left thigh, prescribed antibiotics, follow up.
Sore and slightly swollen arm near injection site-3 days ( felt bruised and lessened each day) Warm and red by injection site- ongoing but lessening each day. Burning itchy feeling around injection site- ongoing  Chills and achy body ( 1.5 days) Fatigue ( 2 days) Slight Cough  - ongoing
Dry, flaky and swollen rash on face. Left cheek, right cheek and right side bridge of nose, and under chin on left side. I noticed it on 1/12/21 and it got progressively worse by 1/14/21.
Pounding heart; Fatigue; Poor circulation on left side of body; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included Urinary tract infection and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included unspecified antibiotics for urinary tract infection (UTI) from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Jun2021 at 16:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 12Sep2021, the patient experienced pounding heart, fatigue and poor circulation on left side of body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 04Aug2021, the patient underwent amazon test via nasal swab and the result was negative. The clinical outcome of the events pounding heart, fatigue and poor circulation on left side of body was resolving at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
I was very tired. My electrolytes were very low and I started to vomit and shake. I went to the ER and they told me my electrolytes were low and I went into a-fib.
Mom relates child had fever 101-102, not sleeping for 3-4 days, screaming, unusual behavior, also rash over body, MD said allergic rxn to shots-was given Benadryl Elix,recovering but not completely /p 7 days,con't decreased appetite &upset
STARTED WITH SYMPTOMS ON 9/13/2019: REPORTS PULSATING B/L ARMS WITH PAIN, FATIGUE & HA'S AFTER RECEIVING VACCINE
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding the patient's historical conditions, previous drug reactions, allergies, concurrent conditions or concomitant medications.  On an unspecified date in 2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for for the long-term prevention of herpes zoster or shingles (prophylaxis) (dose, route of administration, lot number and expiration date were not reported).         On an unknown date, the patient experienced herpes zoster, which required hospitalization and the patient received treatment for the event. The lawyer specified that the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; significant medical and related expenses as a result of these injuries, including but not limited to costs for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages.  The outcome of herpes zoster is unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
Contracted COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Contracted COVID) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced COVID-19 (Contracted COVID). At the time of the report, COVID-19 (Contracted COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided.  Treatment information was not provided.
Jammed my ring finger on my left hand and it didn't get better. I went to urgent care and x-ray was negative. I had a physical exam scheduled in May and I mentioned it there. The injury took forever for it to go away, but my hands are still sore and they're weak. My fingers kind of get stuck. The joints sometimes stick; I'm on the computer a lot and I do a lot of writing. She sent me to arthritis specialist, and she said that I definitely have arthritis in my left hand. I am getting bloodwork done soon as she ordered. Arthritis runs in my family.
Case number PHEH2016US018308 is an initial spontaneous report received from nurse on 19 Jul 2016. This report refers to an unknown demographics patient. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 157804, expiry date: Apr 2016) at dose of 0.5 ml intramuscularly and BEXSERO (batch number: 151301C, expiry date: Dec 2016) intramuscularly in Apr 2016. In Apr 2016, throughout the month FLUVIRIN had several low temperature. The lowest excursion was 1.4 C for up to 5 hour and 18 minutes. Vaccine was not frozen. The reporter was not sure if the vaccine had been given since the first excursion in Apr 2016. The reporter states they usually did not give much vaccine after Mar, but reporter was not able to confirm that no one receive it and was unable to access the files to see if any vaccine had been given after the first excursion. The nurse reported that, no patients were given FLUVIRIN. The outcome of event was reported as unknown. The seriousness of event was reported as non serious. The causality of event was not reported. Follow up report received from a nurse on 20 Sep 2016: updated reporters comments.
Administration error: parent presented requesting Moderna for dose #2, forgetting they had originally gotten Pfizer for dose #1
This spontaneous report as received from a nurse refers to unknown patients of unkonwn age. On an unknown date since 10-JUN-2014, patients was vaccinated with doses GARDASIL (lot#, expiration date, dose, route not reported) which were improperly stored. No adverse effects reported. This is one of the several reports from the same source. Additional information is not expected.
Pt. was complaining of abd. cramping, shaking, twitching, lethargy within a course of 3 hours. Pt. also had a fever of 103. Tylenol was administered by parent.
Patient complains of "severe itching" from head to toe. Patient given Benadryl and Claritin by doctor.
17 years old was given the first dose of Moderna Covid19 Vaccine; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Apr-2021. The most recent information was received on 06-Jul-2021 and was forwarded to Moderna on 06-Jul-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was given the first dose of Moderna Covid19 Vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was given the first dose of Moderna Covid19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 years old was given the first dose of Moderna Covid19 Vaccine) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient taken second vaccine prior to 18th birthday. No concomitant medication were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant Follow-up appended patient second dose information were added.
A couple days after receiving the second booster my arm started hurting all the way down to my hand. It has now started to become a problem for me to be able to drawl my fingers up or even make a fist. I went to see my Primary Care Physician in June and had an EEG done and they could not find a reason for the radiating pain. I have extreme fatigue.
WHEN HE CAME BACK FOR HIS 2ND DOSE ON 6/20/21, HE MENTIONED THAT THE 1ST VACCINE GAVE HIM A RASH. IT STARTED APPROXIMATELY ON 6/20/21 ON HIS UPPER BACK.  HE DID STATE THAT HE WAS DOING YARD WORK THE DAY BEFORE THE RASH STARTED, AND HE SAID IT DID LOOK LIKE A HEAT RASH. HE NEVER SAW A DOCTOR FOR IT, IT RESOLVED ON ITS OWN. HE DID RECEIVED THE 2ND DOSE ON 7/8/2021. HE WILL REACH OUT TO ME IF IT HAPPENS AGAIN, SO I WON'T UPLOAD THIS UNTIL NEXT WEEK.
Shivers started 4:20pm Numbness in hands started 4:45pm Fever started 5:15pm Highest fever temp at 1:15am of 102.9° Fever broke to below 100° at 4am Fever gone by 8am Low energy and sore muscles through 3/14/2021
Rash on left breast few days after 2nd shot.  Went to dermatologist, got triamcinolone cream .1%.  Getting worse, went to 2nd dermatologist, got bethametasone ointment.  Getting worse.  Went to family doctor, 10 days of prednisone.  Getting better, off prednisone and skin exploded.  Went to immunologist, 3 weeks of prednisone and mometasone cream.  No better.  2 weeks later prescribed Dupixent.  2 days after Dipixent shots skin exploded with inflamed rash on back, chest, stomach, arms, neck and legs.  Went to holistic doctor who prescribed bromelian and selenium.  Seems to be working.
pt received Hepatitis b vaccine, 3 rd shot @ 0855 am 02/16/07, approx 12:15 am felt dizzy, nauseated and headache as stated.  States feels ok prior to coming to work.  -----not feelin sick.
Headache; Fever 100; Nausea; Vomiting; Chills; This is a spontaneous report from a contactable other healthcare professional (patient). A non-pregnant 41-year-old female adult patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL3248), via an unspecified route of administration on left arm on 25Jan2021 at 11:00 AM as a single dose for COVID-19 immunization. Patient had allergies to Celexa, Mango, Mold, Penicillin, Amoxicillin, Cocoa, Dairy. Patient received Allergy Shots, Cetirizine Hydrochloride (Zyrtec), Lisinopril, Verapamil, and Amitriptyline Hydrochloride (Amit) within 2 weeks of vaccination on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID. On 01Feb2021 patient experienced Headache, Fever 100, nausea, vomiting and chills. No treatment received for the adverse events . since the vaccination, patient has not been tested for COVID-19. case has been assessed as non-serious. Outcome of all the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Unable to move arm, pain, redness, and rash at the injection site. Patient reports that they vomited, became dizzy, and experienced shortness of breath. Transported to hospital and diagnosed with an infection at the injection site.
Pt received vaccines on 8-16-13 as part of a well visit. On the evening of 8-18-13, pt's left upper thigh, where vaccines were administered, swelled, becoming red, hard, and warm to the touch. Seen at ER, dx'ed with cellulitis as a reaction to the vaccine, put on KEFLEX 10 day course. Had a follow-up appt at our office on.
macular-papular somewhat erythematous exanthema on face & upper chest w/circular erythema on lt thigh in two places around inj site;mom reports pt fussy & crying a lot since vax & child w/fever but did not take temp;plan: DT only in future
Polymyalgia Rheumatica and possible autonomic neuropathy after 2nd vaccine requiring long term steroid use and possible other future treatments.
Patient's mom told the RpH that she has thrown up; not feeling good about 5 to 10 min after receiving the flu shot. Patient was talking, breathing normal but looked tired; white in the face. She lied down had some water felt better. RPH regularly checked on her. Her dad came got.
DOSE 1      " Covid Arm"   warm to touch, red, started 10th day and lasted 10 days.  "grew" from size of a quarter coin to about 6 inches diagonally across bicep.   Discolored for a few days after redness left.  No treatment.
MINOR FLARE; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included psoriasis vulgaris, and other pre-existing medical conditions included The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported.  The Company is unable to perform follow-up to request batch/lot number. Concomitant medications included guselkumab for psoriasis vulgaris. On an unspecified date, the subject experienced minor flare. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of minor flare was not reported. This report was non-serious.